| Pyrazole-pyrazoline as promising novel antimalarial agents: A mechanistic study G Kumar, O Tanwar, J Kumar, M Akhter, S Sharma, CR Pillai, MM Alam, ... European journal of medicinal chemistry 149, 139-147, 2018 | 80 | 2018 |
| Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update K Engle, G Kumar European Journal of Medicinal Chemistry 239, 114542, 2022 | 70 | 2022 |
| Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents G Kumar, V Siva Krishna, D Sriram, SM Jachak Archiv der Pharmazie 353 (8), 2000077, 2020 | 40 | 2020 |
| Synthesis of carbohydrazides and carboxamides as anti-tubercular agents G Kumar, VS Krishna, D Sriram, SM Jachak European Journal of Medicinal Chemistry 156, 871-884, 2018 | 17 | 2018 |
| Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations O Tanwar, GS Deora, L Tanwar, G Kumar, S Janardhan, MM Alam, ... Journal of molecular modeling 20, 1-16, 2014 | 14 | 2014 |
| Targeting mycobacterial membranes and membrane proteins: Progress and limitations G Kumar, S Kapoor Bioorganic & Medicinal Chemistry 81, 2023 | 13 | 2023 |
| Chemical tools for illumination of tuberculosis biology, virulence mechanisms, and diagnosis G Kumar, R Narayan, S Kapoor Journal of Medicinal Chemistry 63 (24), 15308-15332, 2020 | 13 | 2020 |
| Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents G Kumar, A Sathe, VS Krishna, D Sriram, SM Jachak European Journal of Medicinal Chemistry 157, 1-13, 2018 | 13 | 2018 |
| Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors G Kumar, AK Tudu Bioorganic & Medicinal Chemistry 80, 117187, 2023 | 12 | 2023 |
| Natural products acting against S. aureus through membrane and cell wall disruption KE Gautam Kumar Natural Product Reports, 1-39, 2023 | 5* | 2023 |
| Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update GK Amrutha C Drug Development Research, 1-26, 2023 | 5* | 2023 |
| Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus N Chandal, R Tambat, R Kalia, G Kumar, N Mahey, S Jachak, ... Microbiology Spectrum 11 (5), e04876-22, 2023 | 3 | 2023 |
| Targeting Mycobacterium tuberculosis iron- scavenging tools: a recent update on siderophores inhibitors GKPA Adhikrao RSC Medicinal Chemistry, 2023 | 3 | 2023 |
| Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors G Kumar, AG Godavari, R Tambat, S Kumar, H Nandanwar, ME Sobhia, ... Bioorganic Chemistry 104, 104225, 2020 | 3 | 2020 |
| Tackling influenza a virus by M2 ion channel blockers: Latest progress and limitations G Kumar, KA Sakharam European Journal of Medicinal Chemistry, 116172, 2024 | 1 | 2024 |
| Microemulsions, nanoemulsions and emulgels as carriers for antifungal antibiotics A Padaraju, F Dwivedi, G Kumar Therapeutic Delivery 14 (11), 721-740, 2023 | 1 | 2023 |
| Biaryl carboxamide‐based peptidomimetics analogs as potential pancreatic lipase inhibitors for treating obesity V Pandey, PA Adhikrao, GM Motiram, N Yadav, U Jagtap, G Kumar, ... Archiv der Pharmazie, e2300503, 2024 | | 2024 |
| Natural Products and Traditional Herbal Medicines as Managerial Therapies to Combat Rheumatoid Arthritis N Ghosh, S Pathak, Malsawmdawngkimi, G Kumar, A Gull Clinical & Translational Metabolism 22 (2), 1-17, 2024 | | 2024 |
| Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight GK Rutuja Damare, Kritika Engle Phytotherapy Research, 1-42, 2024 | | 2024 |
| Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products PA Adhikrao, GM Motiram, G Kumar Current Topics in Medicinal Chemistry, 2024 | | 2024 |
